Ann: ePAT validation tests successful-MNQ.AX, page-5

Had a feeling it would CSIRO won't choose you on a pipe dream concept only

The announcement says and has said previously this has been in development for 3.5yrs , it's now with MNQ they are ramping up the commercial side of things.

I think this a little closer to commercial product to market than what perhaps some market observers think

But we'll know when further news flow around FDA approvals etc take place

The strong performance and $150M market cap of RAP will also help MNQ share price

Good valuation play this one over the course of this year